Translational and clinical cancer research plays a vital role in turning laboratory discoveries into real-world medical treatments. This field focuses on applying insights from basic science to develop novel therapies, aiming to enhance the quality of patient care. It encompasses the exploration of cancer mechanisms, the identification of potential biomarkers, and the testing of treatments through clinical trials. By bridging the gap between research and patient care, this approach fosters the creation of targeted therapies that are both innovative and personalized. As a result, translational and clinical research accelerates the delivery of cutting-edge cancer treatments to patients in need.
Title : The role of artificial intelligence (AI) in oncology
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom
Title : Altered expression of endoplasmic reticulum stress response genes and circular RNAs in oral squamous cell carcinoma tumorigenesis
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom